[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
December 2, 1998

Symptomatic Treatment of Painful Neuropathy

Author Affiliations

From the Department of Neurology, Mayo Clinic, Rochester, Minn.

JAMA. 1998;280(21):1863-1864. doi:10.1001/jama.280.21.1863

Pain resulting from diffuse and focal neuropathies, such as painful diabetic neuropathy (PDN) and postherpetic neuralgia (PHN), is a relatively common but difficult to manage clinical problem. Neuropathy occurs in more than 50% of patients with diabetes who have been hyperglycemic for more than 15 years,1 and about 10% of patients with diabetic neuropathy are troubled with persistent dysesthesias or pain. Unfortunately, drug treatment for PDN is often unsatisfactory, as eloquently demonstrated by the large number of drugs that patients will have taken in an attempt to seek relief.

First Page Preview View Large
First page PDF preview
First page PDF preview
×